|
1
|
Ferreri AJ, Reni M, Zoldan MC, Terreni MR
and Villa E: Importance of complete staging in non-Hodgkin’s
lymphoma presenting as a cerebral mass lesion. Cancer. 77:827–833.
1996.
|
|
2
|
Warren S and Gates O: Multiple primary
malignant tumors: a survey of the literature and statistical study.
Am J Cancer. 16:1358–1414. 1932.
|
|
3
|
Bhanote M, Choksi M, Cassar P, Edelman M,
DellaRatta R and Staszewski H: Metastatic adenocarcinoma of the
colon and follicular lymphoma within the same lymph node: a case
report and review of the literature. Int J Gastrointest Cancer.
36:171–175. 2005. View Article : Google Scholar
|
|
4
|
Devi P, Pattanayak L and Samantaray S:
Synchronous adenocarcinoma and mucosa-associated lymphoid tissue
lymphoma of the colon. Saudi J Gastroenterol. 17:69–71. 2011.
View Article : Google Scholar
|
|
5
|
Cornes JS: Multiple primary cancers:
primary malignant lymphomas and carcinomas of the intestinal tract
in the same patient. J Clin Pathol. 13:483–489. 1960. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanehira K, Braylan RC and Lauwers GY:
Early phase of intestinal mantle cell lymphoma: a report of two
cases associated with advanced colonic adenocarcinoma. Mod Pathol.
14:811–817. 2001. View Article : Google Scholar
|
|
7
|
Mir-Madjlessi SH, Vafai M, Khademi J and
Kamalian N: Coexisting primary malignant lymphoma and
adenocarcinoma of the large intestine in an IgA-deficient boy. Dis
Colon Rectum. 27:822–824. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Padmanabhan V and Trainer TD: Synchronous
adenocarcinoma and mantle cell lymphoma of the colon. Arch Pathol
Lab Med. 127:E64–E66. 2003.PubMed/NCBI
|
|
9
|
Moriya Y, Koyama Y, Minato K, Shimoyama M,
Hirota T and Itabashi M: Coexisting malignant lymphoma and advanced
adenocarcinoma of the colon - a case report. Gan No Rinsho.
31:894–899. 1985.(In Japanese).
|
|
10
|
Chang H, Chuang WY, Shih LY and Tang TC:
Collision in the colon: concurrent adenocarcinoma and diffuse large
B-cell lymphoma in the same tumour. Acta Clin Belg. 66:302–304.
2011.
|
|
11
|
Bavi P, Uddin S, Bu R, Ahmed M, Abubaker
J, Balde V, Qadri Z, Ajarim D, Al-Dayel F, Hussain AR and Al-Kuraya
KS: The biological and clinical impact of inhibition of
NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
J Pathol. 224:355–366. 2011.
|
|
12
|
Markovic O, Marisavljevic D, Cemerikic V,
Perunicic M, Savic S, Filipovic B and Mihaljevic B: Clinical and
prognostic significance of apoptotic profile in patients with newly
diagnosed nodal diffuse large B-cell lymphoma (DLBCL). Eur J
Haematol. 86:246–255. 2011. View Article : Google Scholar
|
|
13
|
Pedersen MØ, Gang AO, Poulsen TS, Knudsen
H, Lauritzen AF, Nielsen SL, Gang UO and Nørgaard P: Double-hit
BCL2/MYC translocations in a consecutive cohort of patients with
large B-cell lymphoma - a single centre’s experience. Eur J
Haematol. 89:63–71. 2012.
|
|
14
|
Schrader A, Bentink S, Spang R, Lenze D,
Hummel M, Kuo M, Arrand JR, Murray PG, Trümper L, Kube D and
Vockerodt M: High Myc activity is an independent negative
prognostic factor for diffuse large B cell lymphomas. Int J Cancer.
131:E348–E361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sharrard RM, Royds JA, Rogers S and
Shorthouse AJ: Patterns of methylation of the c-myc gene in human
colorectal cancer progression. Br J Cancer. 65:667–672. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun N, Meng Q and Tian A: Expressions of
the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their
relationship. Am J Surg. 200:341–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiaoyuan C, Longbang C, Jinghua W,
Xiaoxiang G, Huaicheng G, Qun Z and Haizhu S: Survivin: a potential
prognostic marker and chemoradiotherapeutic target for colorectal
cancer. Ir J Med Sci. 179:327–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
